Zaprinast (ZAP) increases cGMP levels in plasma and aortic tissue of SH rats von Dundore, R.L., Clas, D.M., Wheeler, L.T., Habeeb, P.G., O'Connor, B., Buchholz, R.A., Silver, P.J., Pagani, E.D.

Volltext

A new approach to the development of drugs for the management of heart failure von Pagani, E.D., Alousi, A.A.

Volltext

Tension-pCa relations of saponin-skinned rabbit and human heart muscle von Pagani, E.D., Shemin, R., Julian, F.J.

Volltext

Global best practices consensus: long-term management of patients with hybrid centrifugal flow left ventricular assist device support von Hayward, C., Adachi, I., Baudart, S., Davis, E., Feller, E.D., Kinugawa, K., Klein, L., Li, S., Lorts, A., Mahr, C., Mathew, J., Morshuis, M., Muller, M., Ono, M., Pagani, F.D., Pappalardo, F., Rich, J., Robson, D., Rosenthal, D.N., Saeed, D., Salerno, C., Sauer, A.J., Schloglhofer, T., Tops, L., VanderPluym, C.

Volltext bestellen